← FDA DRUG APPROVALS

FDA ANDA · ANDA204226

CHILDRENS CETIRIZINE HYDROCHLORIDE

cetirizine hcl

Sponsor: PERRIGO R AND D

APPLICATION
ANDA204226
TYPE
ANDA
ORIGINAL APPROVAL
2013-09-09
LATEST ACTION
2015-04-15
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Over-the-counter

Products

CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGYOver-the-counter
CETIRIZINE HYDROCHLORIDE 5MG/5ML · SOLUTION · ORAL

Approval history

2015-04-15Labeling · Supplement 5 · standardAP
2013-09-09UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →